Truveta news For media inquiries, please email news@truveta.com Our journey of applying generative AI to advance healthcare April 24, 2024 Truveta wins SXSW Innovation Award for Artificial Intelligence March 13, 2024 Cardiac catheterization reports now available in Truveta Data at scale to advance cardiovascular research February 29, 2024 Truveta named SXSW Innovation Awards finalist in Artificial Intelligence for AI-enabled health research January 25, 2024 Truveta awarded real-world data contract by the CDC to study COVID, maternal health, and pediatric care January 22, 2024 Reflections from the inaugural Truveta Symposium November 20, 2023 Availability of millions of echocardiogram reports make Truveta the market leader in data for cardiovascular research November 8, 2023 Truveta community expands to more than 50 organizations October 23, 2023 « Previous 1 … 5 6 7 … 11 Next » Truveta in the news Children who miss early vaccines more likely to not get the MMR shot by age 2 Women with PCOS seek relief in weight-loss drugs Weight Loss Drugs Now Account For 1 In 14 Prescriptions, Study Says FDA to streamline approvals for generic biological drugs in latest move targeting health costs See all articles Recent press releases The CHOICE Institute partners with Truveta to advance health economics and outcomes research September 4, 2024 Truveta’s real-world data study comparing tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss published in JAMA Internal Medicine July 8, 2024 Truveta announces support for regulatory submissions to the FDA and global regulatory authorities June 17, 2024 Truveta welcomes Rod Hochman, MD, president and CEO of Providence, as new Truveta Board of Directors Chair May 13, 2024 See all press releases Images Truveta logo Format: PNG Truveta Data Map Format: PNG Truveta Health System Members Format: PNG
Cardiac catheterization reports now available in Truveta Data at scale to advance cardiovascular research February 29, 2024
Truveta named SXSW Innovation Awards finalist in Artificial Intelligence for AI-enabled health research January 25, 2024
Truveta awarded real-world data contract by the CDC to study COVID, maternal health, and pediatric care January 22, 2024
Availability of millions of echocardiogram reports make Truveta the market leader in data for cardiovascular research November 8, 2023
The CHOICE Institute partners with Truveta to advance health economics and outcomes research September 4, 2024
Truveta’s real-world data study comparing tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss published in JAMA Internal Medicine July 8, 2024
Truveta announces support for regulatory submissions to the FDA and global regulatory authorities June 17, 2024
Truveta welcomes Rod Hochman, MD, president and CEO of Providence, as new Truveta Board of Directors Chair May 13, 2024